A total of 3,082 breast cancer patients with RFS data and 1,044 with OS data and estrogen receptor (ER) positive status; and 869 (RFS) and 358 (OS) patients with ER-negative status were analyzed (Table 3). This evidence concerns the gene ESR1 and breast carcinoma.